The American Conference Institute is holding an event called “FCPA and Anti-Corruption for Life Science Companies” from Monday, May 18th through Tuesday, May 19th at the Helmsley Park Lane Hotel in New York, NY.
A recent program sponsored by the Seton Hall Law Center for Health and Pharmaceutical Law & Policy urged health care and life sciences companies to place a high degree of emphasis on developing and maintaining effective corporate compliance programs.
Scott Bruns and Kathleen Meriwether of Ernst & Young count down the top five compliance risks facing life sciences companies, including sales & marketing risks, the FCPA and IFRS, as well as supply-chain integrity and aggregate spend.
